Thalassemia: Genetics and Pregnancy

Thalassemia Genetics Pregnancy

If a genetic condition called thalassemia runs in your family, there are several potential issues that you’ll need to consider along the pathway related to family planning and genetic counseling, to giving birth, and to raising your child. We’ll touch on those issues in the context of an overview of this condition. Thalassemia is a group of genetic diseases affecting red blood cells (RBCs) due to a problem in the production of hemoglobin, the oxygen-carrying molecule that fills each RBC. Each molecule of hemoglobin consists of four chemical entities called heme groups, each with an iron atom at its center that allows it to grab and release a molecule of oxygen (O2) and four protein chains called globins (see image below).

The group of four globins consists of pairs of two different types of globins, each of which is produced from instructions of particular genes. In a healthy adult, the main two types of globins are called alpha globin and beta globin. For the hemoglobin molecule to work correctly, it must consist of two alpha globin chains and two beta globin chains. However, if one or more genes that carry instructions for either alpha or beta globin–known as alpha globin gene and beta globin gene–are missing or are defective, the result is thalassemia, which is a deficiency of either the alpha globin or beta globin chain. If alpha globin production is inadequate, the condition is called alpha thalassemia, whereas if beta globin production is inadequate, the condition is known as beta thalassemia.

The genetics of thalassemia

In contrast with sickle cell anemia and certain other hemoglobin conditions in which the problem is production of a defective hemoglobin chain (in other words a qualitative problem), thalassemia is a quantitative problem with a hemoglobin chain. The genetics underlying both alpha and beta thalassemia is very complex, but there are a couple of points worth mentioning. The first is that most people carry two copies of the beta globin gene (one received from each parent) and four copies of the alpha globin gene (two from each parent). The other point is that most cases beta thalassemia result the presence of defects in one or both of the beta globin genes, whereas alpha thalassemia usually results from one or more of the alpha globin genes being absent. In cases when just one of the four alpha globin genes is absent, you would experience no symptoms and the condition is barely noticeable, even in standard blood tests (although it is easily detectable in genetic testing). On the other extreme, if a fetus is missing all four alpha globin genes, the condition is fatal and so health issues come into play during childhood and adult life, when two or three alpha genes are missing.

The severity of thalassemia

In the case of beta thalassemia, generally you may be affected minimally, if at least one of your two beta globin genes is normal. However, the situation varies since there are different types of defects that can exist in a beta globin gene, some causing a complete lack of production of beta globin from the affected copy of the gene but others causing reduced production. When both copies of the beta globin gene are abnormal, the severity of the beta thalassemia can vary substantially, depending on whether one or both gene copies are of the low-production or no-production type. Additionally, the severity of beta thalassemia is affected by the degree to which your blood cells have continued to make the fetal equivalent of beta chains, known as gamma chains.

As for the consequences of having thalassemia for pregnancy, this depends on the severity of your condition. With mild forms of thalassemia, pregnancy can trigger anemia, which may be partly due to iron deficiency related to pregnancy and partly from the thalassemia itself.

The classification of thalassemia

As a result of the various differences in chain production and resulting symptom severity, both alpha and beta thalassemia are classified as being minor or major plus there are various intermediate scenarios. You also may hear the term alpha or beta thalassemia trait. This means that you have minimal or no symptoms, but you are a carrier for a genetic makeup that can lead to thalassemia in your children. For instance, if you have one defective beta globin gene that gives you beta thalassemia minor, there is a 50 percent chance of passing that gene to your child each time you conceive. If the child receives the gene, he or she would be a carrier and could experience mild symptoms. However, if the child also receives a defective copy of the beta globin gene from her father, then she could end up with beta thalassemia major, a much more severe condition that includes frequent anemia and a frequent need for transfusion of donated RBCs.

Epidemiology of thalassemia

Thalassemia is fairly common, but your chances of having it depend greatly on your ancestry. Alpha thalassemia is most common in populations of Africa, Southeast Asia, Central America, the Mediterranean, and Middle East. Beta thalassemia also can occur in populations of the Mediterranean, Africa, and Southeast Asia, and also India, but it is particularly common in Greece, Italy, Coastal Turkey, Cyprus, and Sardinia. Thus, women who are mothers to be or who are planning motherhood and have Mediterranean roots should be tested for beta thalassemia and should receive genetic counseling.

Thalassemia in pregnancy

As for the consequences of having thalassemia for pregnancy, this depends on the severity of your condition. With mild forms of thalassemia, pregnancy can trigger anemia, which may be partly due to iron deficiency related to pregnancy and partly from the thalassemia itself. With an intermediate form of thalassemia you may experience some complications, but usually these can be managed by your obstetrician along with a blood specialist called a hematologist. With still more severe thalassemia, such as beta thalassemia major, successful pregnancy may be difficult as complications can be significant and tend to increase as quantities of iron build up in organs as a result of transfusions of RBCs given as treatment for anemia. In some women with beta thalassemia major, the spleen may grow to be very large and may need to be removed surgically, which increases the risk of infections and blood clots. Anemia also can be severe, require blood transfusions, and combined with the stresses of pregnancy may lead to heart failure.

David Warmflash
Dr. David Warmflash is a science communicator and physician with a research background in astrobiology and space medicine. He has completed research fellowships at NASA Johnson Space Center, the University of Pennsylvania, and Brandeis University. Since 2002, he has been collaborating with The Planetary Society on experiments helping us to understand the effects of deep space radiation on life forms, and since 2011 has worked nearly full time in medical writing and science journalism. His focus area includes the emergence of new biotechnologies and their impact on biomedicine, public health, and society.

Leave a Reply